UP!

VSI $6.5

VSI target price
6.50
0
0
Vitamin Shop Industries Inc.
Type
Public (60% privately owned)
Traded as NYSE: VSI
S&P 600 Component
Industry Retail
Founded 1977
Headquarters North Bergen, New Jersey, United States
Number of locations
775 (December 2016)
Key people

Colin Watts, CEO;

Brenda M. Galgano, Executive VP and CFO
Products Nutritional supplements
Website www.vitaminshoppe.com

Colin Watts, CEO;

The Vitamin Shoppe (formerly Vitamin Shoppe Industries, Inc., stylized as theVitaminShoppe) is an American, New Jersey-based retailer of nutritional supplements. It also operated 3 stores in Canada under the name VitaPath from January 2013 until March 2016. The company provides approximately 8,000 different SKUs of supplements through its retail stores and over 20,000 different SKUs of supplements through its retail websites.

In 2002, Vitamin Shoppe Industries was sold to an affiliate of Bear Stearns Merchant Banking, a private equity unit of Bear Stearns, for approximately $310 million.

The Vitamin Shoppe held an initial public offering on October 26, 2009. The company made $751.5 million in net sales in fiscal 2010 and had a market capitalization of over $1 billion.. Since attaining it's peak in February 2013 the stock has lost more than 90% of it's value as of August 2017.

Jeffrey Horowitz founded The Vitamin Shoppe in 1977.

The Vitamin Shoppe's retail stores and online sites carry a line of nutritional supplements with supplementary lines, such as Mytrition, Next Step, ProBio Care, plnt and the Bodytech brand of sports supplements. In addition to their own brands, the company carries third-party lines, including professional and specialized lines.

A 2015 study, led by Dr. Pieter A. Cohen of Harvard, found that three supplements — JetFuel Superburn, JetFuel T-300 and MX-LS7 — sold at Vitamin Shoppe contained BMPEA. In response, Vitamin Shoppe removed these products from shelves because the safety of these supplements were in question and may not comply with F.D.A. regulations.

On January 19, 2007, independent laboratory ConsumerLab.com found 32.8 micrograms of lead per daily serving in Vitamin Shoppe's "Especially for Women" multivitamin. 15.3 micrograms is more than ten times the amount of lead permitted without a warning label in California, the only state to regulate lead in supplements. The amount of lead found was found to cause cancer and death to 29 people nationwide. In the wake of extensive adverse media coverage, Vitamin Shoppe withdrew the product, but in a statement made by CEO Tom Tolworthy denied it had any proof the vitamins were contaminated and asserted that, despite the high lead levels found in the Consumer Labs tests, its vitamins were manufactured in accordance with "good manufacturing practices."

On June 15, 2011, Vitamin Shoppe's Ultimate Woman Gold multivitamin was tested by ConsumerLab.com in their Multivitamin and Multimineral Supplements Review of 38 of the leading multivitamin/multimineral products sold in the U.S. and Canada. This multivitamin passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2019 2019-11-05 0.00 0.00
Q2 2019 2019-08-08 0.20 -0.15
Q1 2019 2019-05-08 0.21 0.15
Q4 2018 2019-02-26 -0.19 -0.14
Q3 2018 2018-11-07 0.04 0.08

Ratings

2016-05-16 Reiterated Rating Robert W. Baird Hold
2016-05-16 Reiterated Rating Sterne Agee CRT Neutral
2016-05-06 Reiterated Rating Jefferies Group Hold $30.00 to $32.00
2016-05-05 Reiterated Rating Macquarie Neutral $40.00
2016-04-30 Downgrade Goldman Sachs Hold
2016-04-30 Downgrade Goldman Sachs Group Inc. Hold
2016-04-26 Reiterated Rating Robert W. Baird Hold
2016-04-20 Initiated Coverage Wedbush Outperform $39.00
2016-04-15 Reiterated Rating Piper Jaffray Neutral $30.00
2016-04-15 Reiterated Rating Piper Jaffray Cos. Neutral $30.00
2016-03-28 Downgrade William Blair Market Perform
2016-02-26 Lower Price Target Goldman Sachs $39.00 to $34.00
2016-02-24 Reiterated Rating Piper Jaffray Neutral $34.00 to $30.00
2016-02-24 Lower Price Target Jefferies Group Hold $36.00 to $30.00
2016-02-24 Reiterated Rating Deutsche Bank Hold $37.00 to $30.00
2016-02-24 Lower Price Target Barclays Equal Weight $35.00 to $31.00
2016-02-24 Reiterated Rating Deutsche Bank AG Hold $37.00 to $30.00
2016-02-24 Lower Price Target Barclays PLC Equal Weight $35.00 to $31.00
2016-02-22 Lower Price Target Sterne Agee CRT Neutral $35.00 to $34.00
2016-01-27 Reiterated Rating Piper Jaffray Neutral $35.00 to $34.00
2016-01-12 Lower Price Target Goldman Sachs $42.00 to $39.00
2016-01-07 Lower Price Target Jefferies Group Hold $36.00
2015-12-13 Reiterated Rating Bank of America Underperform $26.00 to $28.00
2015-12-13 Reiterated Rating Bank of America Corp. Underperform $26.00 to $28.00
2015-11-17 Downgrade Robert W. Baird Outperform to Neutral $38.00 to $31.00
2015-11-05 Lower Price Target Deutsche Bank Hold $41.00 to $37.00
2015-11-04 Reiterated Rating Bank of America Sell
2015-11-04 Reiterated Rating Robert W. Baird Buy
2015-08-07 Downgrade Tigress Financial Buy to Neutral
2015-08-06 Lower Price Target Barclays Equal Weight $40.00 to $38.00
2015-08-06 Reiterated Rating Deutsche Bank Hold $43.00 to $41.00
2015-07-28 Reiterated Rating Robert W. Baird Buy
2015-06-09 Reiterated Rating Guggenheim Neutral $40.00
2015-06-09 Initiated Coverage Macquarie Neutral $40.00
2015-05-07 Set Price Target Barclays Equal Weight $45.00 to $40.00
2015-02-25 Reiterated Rating Jefferies Group Hold $44.00 to $43.00
2015-02-25 Reiterated Rating Piper Jaffray In-Line $42.00
2015-02-25 Downgrade Barclays Overweight to Equal Weight $51.00 to $45.00
2015-02-19 Reiterated Rating Deutsche Bank Hold $43.00
2015-01-08 Downgrade Bank of America Neutral to Underperform $40.00
2014-12-04 Initiated Coverage Stephens Overweight
2014-11-07 Downgrade Goldman Sachs Buy to Neutral $49.00 to $48.00
2014-11-04 Downgrade Wedbush Outperform to Neutral $50.00 to $45.00
2014-11-04 Downgrade Sterne Agee CRT Buy to Neutral $53.00 to $42.00
2014-11-04 Downgrade Deutsche Bank Buy to Hold $50.00 to $43.00
2014-10-01 Reiterated Rating Bank of America Buy $45.00 to $49.00
2014-09-30 Downgrade Piper Jaffray Overweight to Neutral $45.00 to $44.00
2014-09-19 Reiterated Rating Morgan Stanley Overweight $49.00
2014-09-11 Upgrade Morgan Stanley Overweight $49.00
2014-08-06 Reiterated Rating Deutsche Bank Buy $55.00 to $50.00
2014-08-06 Reiterated Rating JPMorgan Chase & Co. Overweight $54.00 to $49.00
2014-08-06 Reiterated Rating Longbow Research Buy $59.00 to $55.00
2014-08-06 Lower Price Target Morgan Stanley $49.00
2014-08-06 Downgrade Goldman Sachs Conviction-Buy to Buy
2014-06-24 Initiated Coverage Morgan Stanley Overweight $54.00
2014-06-04 Upgrade Bank of America Underperform to Neutral $47.00
2014-05-09 Upgrade Barclays Equal Weight to Overweight $49.00 to $51.00
2014-05-09 Boost Price Target Jefferies Group $45.00 to $48.00
2014-04-23 Upgrade Sterne Agee CRT Neutral to Buy $49.00 to $57.00
2014-01-23 Downgrade William Blair Outperform to Market Perform
2013-11-18 Upgrade Goldman Sachs Buy to Conviction-Buy $59.00 to $65.00
2013-11-06 Reiterated Rating Jefferies Group Hold $42.00
2013-11-06 Boost Price Target Deutsche Bank Buy $52.00 to $55.00
2013-11-01 Initiated Coverage Buckingham Research Neutral
2013-10-07 Initiated Coverage Jefferies Group Hold $42.00
2013-09-25 Initiated Coverage Deutsche Bank Buy $52.00
2013-09-24 Initiated Coverage Barclays Equal Weight
2009-12-07 Initiated Stifel Nicolaus Buy $24
2009-11-23 Initiated Pali Research Buy
2016-05-16 Reiterated Rating Robert W. Baird Hold
2016-05-16 Reiterated Rating Sterne Agee CRT Neutral
2016-05-06 Reiterated Rating Jefferies Group Hold $30.00 to $32.00
2016-05-05 Reiterated Rating Macquarie Neutral $40.00
2016-04-30 Downgrade Goldman Sachs Hold

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
SHAH CAPITAL MANAGEMENT 13.84%  (4276142) VSI / XNY /
Vintage Capital Management LLC 11.61%  (3587255) ANEN / VSI /
Watts Colin Frederick Chief Executive Officer 0.42%  (129102) VSI /
TRUESDALE ANTHONY N Chief Executive Officer 0.33%  (102732) VSI /
MARKEE RICHARD L ExecutiveChairman of the Board 0.19%  (60185) FIVE / VSI /
GALGANO BRENDA Chief Financial Officer 0.19%  (60073) VSI /
BOWLIN JOHN D 0.18%  (56028) GNRC / VSI /
Reiser Jason S COO 0.11%  (35405) DG / DLTR / FDO / VSI /
Kastin David See Remarks 0.09%  (29127) CLUB / VSI /
LAMADRID DAN VP, Controller & CAO 0.07%  (22755) ASNA / VSI /
Beardall Michael James See Remarks 0.06%  (18468) VSI /
Weiss Louis VP and Chief Marketing Officer 0.05%  (16923) SSTK / VSI /
ARCHBOLD MICHAEL G President & COO 0.05%  (16476) EXPR / GNC / VSI /
EDWAB DAVID H 0.05%  (16128) MW / NWY / VSI /
ALFONSO ANTHONY President, Nutri-Force 0.05%  (15424) VSI /
FRYDMAN JEAN W See Remarks 0.05%  (15202) VSI /
PRITCHARD BETH M 0.05%  (14268) BRDR / CAB / VSI / ZLC /
DERBY DEBORAH 0.04%  (12904) VSI /
Becker B. Michael 0.04%  (10881) MW / VSI /
Marmol Guillermo 0.03%  (9631) FL / III / VSI /
THERIAULT TIMOTHY J 0.03%  (8631) ADS / VSI / WAG /
Sander James M VP, Gen Counsel & Corp Sec\'y 0.03%  (8081) GNC / VSI /
EDMONDSON JOHN 0.02%  (7206) CAB / VSI /
PERKAL RICHARD 0.02%  (6534) VSI /
Dolgin Tracy Scott 0.02%  (6452) VSI /
SMITH ALEX 0.02%  (6452) PIR / TUMI / VSI /
Buggeln Catherine Elizabeth 0.02%  (5953) ASNA / FIVE / VSI /